| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07a312640f586b6900bcbc6029e219d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8951a6e8bcdf44d47e98404308c9191d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9a3b0fad74598ef6956def61454f7dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ced75aaac0ac8487143559a4eeae655
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfecd8acf24a12ca8fe1201ecda29278 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 |
| filingDate |
2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45def5f2f57ddbad8bb1cc00fae1fe88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_712c362b635f6a55b2c43461c54655d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926c012f89c07d871deb0149c6d55ed0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9596602314b54bec724c2a36c4b0ab0c |
| publicationDate |
2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006129893-A1 |
| titleOfInvention |
Injectable drug carrier comprising layered double hydroxide |
| abstract |
Provided is an injectable drug carrier including a non-toxic Layered Double Hydroxide (LDH) and a pharmaceutically acceptable excipients. Provided is also a method of preparing the injectable drug carrier, the method including: synthesizing LDH with various compositions and controlling the size and shape of the LDH at a level that the LDH has no adverse effect in vivo. A solution obtained by dispersing the LDH in a solvent is injected in vivo. According to the method, nano-size LDH that does not affect a blood vessel in vivo can be synthesized. The LDH thus synthesized has no adverse effect in vivo even at a concentration of 400 mg/kg, and thus can contribute to establishment of a drug delivery system capable of improving the delivery efficiency of a specific drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011059121-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107537071-A |
| priorityDate |
2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |